LifePoint, Inc. (LFPI) Research

LifePoint, Inc. focuses on the development, production, and sale of the IMPACT Test System, a specialized device for diagnostic testing and screening. This product serves a wide array of markets, including businesses, emergency medical services (ambulances), retail pharmacies, public safety organizations, and the home healthcare sector. Established in 1992, the company was formerly known as US Drug Testing, Inc. until it adopted its current name, LifePoint, Inc., in February 1998. Its headquarters are situated in Ontario, California.

Market snapshot

Symbol
LFPI
Price
$0.00
Day change
0.00%
Market cap
$31.3K
P/E ratio
-0.00x
52-week range
0.000001-0.0003
Sector
Healthcare
Industry
Medical - Instruments & Supplies

Peer companies

  • Acutus Medical, Inc. (AFIB)
  • Evelo Biosciences, Inc. (EVLO)
  • Healthtech Solutions Inc. (HLTT)
  • iCoreConnect Inc. (ICCT)
  • OneLife Technologies Corp. (OLMM)
  • SmileDirectClub, Inc. (SDCCQ)
  • Sector 10, Inc. (SECI)
  • Trevena, Inc. (TRVN)

Open LifePoint, Inc. (LFPI) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.